Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, and Department of Clinical Sciences, Lund University, SE-22185 Lund, Sweden. Electronic address: email@example.com.
Survival in cervical cancer has improved little over the last decades. We aimed to elucidate primary treatment patterns and survival.
Population-based study of patients included in the Swedish Quality Registry for Gynecologic Cancer diagnosed 2011-2015. Main outcome was 5-year relative survival (RS). Age-standardised RS (AS-RS) was estimated for the total cohort and for the pooled study population of squamous, adenosquamous-, adenocarcinoma.
Median follow-up time was 4.6?years. The study population consisted of 2141 patients; 97% of the 2212 patients in the total cohort and the 5-year AS-RS was 71% and 70%, respectively. RS stage IB1: surgery alone 95% vs. 72% for definitive chemoradiotherapy (CT-RT) (p?